Skip to content

COMPARATIVE STUDY BETWEEN DEXMEDETOMIDINE AND DEXAMETHASONE AS AN ADJUTANT TO LOCAL ANAESTHETIC IN SUPRA CLAVICULAR BRACHIAL PLEXUS BLOCK

COMPARATIVE STUDY OF DEXMEDETOMIDINE AND DEXAMETHASONE AS AN ADJUVANT IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020417
Enrollment
100
Registered
2019-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK.: PERIPHERAL NERVE STIMULATOR GUIDED SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK. Control Intervention1: NIL: NIL

Sponsors

KALINGA INSTITUTE OF MEDICAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. American society of anaesthesiologists (ASA) physical status I and II. 2. Either sexes (male/female). 3. Age between 20-60 yrs. 4. Upper limb surgeries.

Exclusion criteria

Exclusion criteria: 1. Unwillingness of patient. 2. American society of anaesthesiologists (ASA) physical status III, IV and V patients. 3. Sepsis at the site of injection. 4. Presence of coagulopathies. 5. Hypersensitivity to bupivacaine, Dexmedetomidine drugs.

Design outcomes

Primary

MeasureTime frame
compare time of onset of sensory block and motor block compare duration of sensory and motor blockTimepoint: 1.Onset time of sensory block assessed by spirit cotton swab every 2min after drug injected,till sensory block achieved. 2.Onset time of motor block assessed by Bromage score every 2 min after drug injected, till motor block achieved. 3.duration of sensory and motor block to be assessed every 2 hourly.

Secondary

MeasureTime frame
post operative opioid analgesic requirement with in 24hours after procedure. Timepoint: post operative opioid analgesic requirement with in 24hours after procedure.

Countries

India

Contacts

Public ContactADDURI NAGARAJU

kalinga institute of medical sciences

drlingarajsahu.2008@gmail.com8280166501

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026